Provided by Tiger Trade Technology Pte. Ltd.

Macrogenics

4.02
-0.0800-1.95%
Post-market: 4.00-0.0200-0.50%19:30 EDT
Volume:432.77K
Turnover:1.74M
Market Cap:255.86M
PE:-17.55
High:4.08
Open:4.07
Low:3.97
Close:4.10
52wk High:5.08
52wk Low:1.29
Shares:63.65M
Float Shares:57.01M
Volume Ratio:1.01
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2291
EPS(LYR):-1.1815
ROE:-225.85%
ROA:-8.05%
PB:5.97
PE(LYR):-3.40

Loading ...

BRIEF-FDA Removes Partial Clinical Hold On Macrogenics’ Linnet Study

Reuters
·
Apr 09

MacroGenics Inc - New Participants to Be Enrolled Under Revised Protocol With Additional Risk-Mitigation Measures

THOMSON REUTERS
·
Apr 09

MacroGenics Inc: We Remain on Track to Provide a Mid-Year Clinical Update on Program

THOMSON REUTERS
·
Apr 09

MacroGenics Inc - Plan to Resume Enrollment in Clinical Study of Lorigerlimab in Gynecologic Cancers

THOMSON REUTERS
·
Apr 09

FDA Removes Partial Clinical Hold on MacroGenics’ Linnet Study

THOMSON REUTERS
·
Apr 09

MacroGenics announces annual shareholder meeting

Reuters
·
Apr 09

Stifel Nicolaus Sticks to Its Hold Rating for MacroGenics (MGNX)

TIPRANKS
·
Mar 11

Macrogenics Is Maintained at Overweight by Barclays

Dow Jones
·
Mar 10

Barclays Sticks to Their Buy Rating for MacroGenics (MGNX)

TIPRANKS
·
Mar 10

U.S. RESEARCH ROUNDUP-Adobe, Caseys General Stores, FedEx

Reuters
·
Mar 10

Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Cartesian Therapeutics (RNAC)

TIPRANKS
·
Mar 10

Macrogenics Q4 EPS $(0.22) Beats $(0.48) Estimate, Sales $41.227M Beat $22.643M Estimate

Benzinga Earnings
·
Mar 10

MacroGenics FY2025 net loss widens 11% to USD 74.62 million on revenue of USD 149.5 million

Reuters
·
Mar 10

Press Release: MacroGenics Reports 2025 Financial Results and Highlights Upcoming Planned Data Disclosures

Dow Jones
·
Mar 10

MacroGenics Director Jay Siegel to Step Down from Board

Reuters
·
Mar 03

MacroGenics to Participate in March Investor Conferences

Reuters
·
Feb 27

Why Is MacroGenics Stock Sinking Tuesday?

Benzinga
·
Feb 24

BRIEF-Macrogenics Announces Pausing Of Enrollment Of New Study Participants In Linnet Trial

Reuters
·
Feb 24

FDA places partial clinical hold on MacroGenics’ Phase 2 LINNET trial enrollment

Reuters
·
Feb 24

MacroGenics Announces Pausing of Enrollment of New Study Participants in Linnet Trial

THOMSON REUTERS
·
Feb 24